Sahlin Ellika, Sirotkina Meeli, Marnerides Andreas, Iwarsson Erik, Papadogiannakis Nikos
Department of Molecular Medicine and Surgery and Center for Molecular Medicine, Karolinska Institutet, CMM L8:02, Karolinska University Hospital, S-171 76, Stockholm, Sweden.
Center for Perinatal Pathology and Department of Pathology, Karolinska University Hospital, Huddinge and Karolinska Institutet, S-141 86, Stockholm, Sweden.
PLoS One. 2015 Apr 29;10(4):e0123343. doi: 10.1371/journal.pone.0123343. eCollection 2015.
The biological importance of calcifications occasionally noted in fetal tissues (mainly liver) at autopsy or ultrasound is largely unexplored. Previous reports hint at an association to infection, circulatory compromise, malformations or chromosomal abnormalities. To identify factors associated with calcifications, we have performed a case-control study on the largest cohort of fetuses with calcifications described thus far.
One-hundred and fifty-one fetuses with calcifications and 302 matched controls were selected from the archives of the Department of Pathology, Karolinska University Hospital. Chromosome analysis by karyotyping or quantitative fluorescence-polymerase chain reaction was performed. Autopsy and placenta reports were scrutinized for presence of malformations and signs of infection.
Calcifications were mainly located in the liver, but also in heart, bowel, and other tissues. Fetuses with calcifications showed a significantly higher proportion of chromosomal abnormalities than controls; 50% vs. 20% (p<0.001). The most frequent aberrations among cases included trisomy 21 (33%), trisomy 18 (22%), and monosomy X (18%). A similar distribution was seen among controls. When comparing cases and controls with chromosomal abnormalities, the cases had a significantly higher prevalence of malformations (95% vs. 77%, p=0.004). Analyzed the other way around, cases with malformations had a significantly higher proportion of chromosomal abnormalities compared with controls, (66% vs. 31%, p<0.001).
The presence of fetal calcifications is associated with high risk of chromosomal abnormality in combination with malformations. Identification of a calcification together with a malformation at autopsy more than doubles the probability of detecting a chromosomal abnormality, compared with identification of a malformation only. We propose that identification of a fetal tissue calcification at autopsy, and potentially also at ultrasound examination, should infer special attention towards co-existence of malformations, as this would be a strong indicator for a chromosomal abnormality.
胎儿组织(主要是肝脏)在尸检或超声检查时偶尔发现的钙化的生物学重要性在很大程度上尚未得到探索。既往报告提示其与感染、循环功能障碍、畸形或染色体异常有关。为了确定与钙化相关的因素,我们对迄今为止所描述的最大队列的有钙化的胎儿进行了一项病例对照研究。
从卡罗林斯卡大学医院病理科档案中选取151例有钙化的胎儿和302例匹配的对照。通过核型分析或定量荧光聚合酶链反应进行染色体分析。仔细检查尸检和胎盘报告,以确定是否存在畸形和感染迹象。
钙化主要位于肝脏,但也见于心脏、肠道和其他组织。有钙化的胎儿染色体异常的比例显著高于对照组;分别为50%和20%(p<0.001)。病例中最常见的畸变包括21三体(33%)、18三体(22%)和X单体(18%)。对照组中也观察到类似的分布。在比较有染色体异常的病例和对照时,病例中畸形的患病率显著更高(95%对77%,p=0.004)。反过来分析,有畸形的病例与对照相比,染色体异常的比例显著更高(66%对31%,p<0.001)。
胎儿钙化的存在与染色体异常合并畸形的高风险相关。与仅发现畸形相比,在尸检时发现钙化和畸形会使检测到染色体异常的概率增加一倍以上。我们建议,在尸检时以及可能在超声检查时发现胎儿组织钙化,应特别关注是否并存畸形,因为这将是染色体异常的一个有力指标。